Cracking Down on Overdose Deaths
FDA approves first over-the-counter treatment to combat the opioid overdose epidemic.
Patent Law Could Also Limit Mifepristone Access
Existing patents deter the marketing of more affordable generic drugs that could be used off-label for abortions.
FDA’s Role in Access to Reproductive Health Care
Recent abortion pill litigation underscores the significance of calls to make birth control pills available over the counter.
Sugar, Spice, Are Additives Nice?
Scholar argues that loopholes in U.S. food regulation put consumers at risk.
Are Food Regulators Stepping up to the Plate?
In this week’s Saturday Seminar, we collect scholarship discussing quality and safety issues within U.S. food regulation.
Hallucinate, Medicate, and Regulate
In this week’s Saturday Seminar, experts discuss ways to regulate psychedelics for medicinal use.
Emergency Use or Overuse?
Experts discuss FDA’s COVID-19 emergency authorizations and how to recalibrate the regulatory mechanism.
Hidden Racial Disparities in FDA-Required Research
Current testing practices in the pharmaceutical industry exploit social and racial inequities.
Disclosing Gluten in Food
Pending federal legislation would improve food information for consumers with gluten sensitivity.
Value-Pricing Prescription Drugs
Scholar argues that reducing pricing for prescription drugs may increase innovation.
Pet Food Regulations May Be More Bark Than Bite
Regulators strive to keep our animal companions’ food safe, but gaps remain.
Something Fishy About Seafood Inspection
Government watchdog finds that FDA is not properly inspecting imported seafood.